A groundbreaking medical platform from Mason could help doctors detect heart problems in less than five minutes. Its origin? An Ohio State University dropout turned entrepreneur.
Peeyush Shrivastava, CEO and co-founder of Genetesis, recalls the medical technology company’s early days as “a dorm-room startup.” Now, it’s getting closer to emergency room implementation as its flagship cardiac imaging platform received FDA 510(k) clearance in March 2019.
Click here to read the complete article.
Story excerpt provided by CincyInno.
Written by Stephanie Vermillion.
Originally published Sept. 5, 2019.